Secalip

Secalip Brand names, Secalip Analogs

Secalip Brand Names Mixture

No information avaliable

Secalip Chemical_Formula

C₂₀H₂₁ClO₄

Secalip RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Secalip fda sheet

Secalip FDA

Secalip msds (material safety sheet)

Secalip MSDS

Secalip Synthesis Reference

No information avaliable

Secalip Molecular Weight

360.831 g/mol

Secalip Melting Point

80.5 °C

Secalip H₂O Solubility

0.25mg/ml at 25 °C

Secalip State

Solid

Secalip LogP

5.575

Secalip Dosage Forms

Capsule; Tablet

Secalip Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Secalip Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Secalip Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Secalip side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Secalip Patient Information